edelfosine has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gajate, C | 1 |
| Gonzalez-Camacho, F | 1 |
| Mollinedo, F | 1 |
1 other study available for edelfosine and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 8; fas Receptor; Fas-Associated Death Domain Protein; Huma | 2009 |